Barbara C. Fullerton, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Evoked Potentials, Auditory, Brain Stem | 8 | 2005 | 253 | 0.490 |
Why?
|
| Chordoma | 6 | 2023 | 347 | 0.440 |
Why?
|
| Skull Base Neoplasms | 5 | 2023 | 270 | 0.430 |
Why?
|
| Photons | 7 | 2018 | 589 | 0.400 |
Why?
|
| Chondrosarcoma | 6 | 2023 | 296 | 0.310 |
Why?
|
| Temporal Lobe | 3 | 2021 | 1695 | 0.300 |
Why?
|
| Auditory Pathways | 6 | 2005 | 237 | 0.300 |
Why?
|
| Radiation Injuries | 6 | 2021 | 1189 | 0.280 |
Why?
|
| Radiotherapy, Intensity-Modulated | 4 | 2021 | 801 | 0.260 |
Why?
|
| Radiotherapy, Conformal | 6 | 2013 | 548 | 0.260 |
Why?
|
| Cochlear Nucleus | 2 | 2005 | 60 | 0.250 |
Why?
|
| Inferior Colliculi | 3 | 2005 | 69 | 0.250 |
Why?
|
| Olivary Nucleus | 2 | 2005 | 128 | 0.240 |
Why?
|
| Brain Stem | 10 | 2000 | 858 | 0.240 |
Why?
|
| Protons | 6 | 2024 | 1116 | 0.240 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 9 | 2021 | 1661 | 0.230 |
Why?
|
| Auditory Cortex | 2 | 2007 | 363 | 0.230 |
Why?
|
| Meningioma | 3 | 2019 | 1218 | 0.220 |
Why?
|
| Meningeal Neoplasms | 3 | 2019 | 1248 | 0.210 |
Why?
|
| Relative Biological Effectiveness | 2 | 2021 | 312 | 0.200 |
Why?
|
| Radiotherapy Dosage | 12 | 2024 | 2898 | 0.190 |
Why?
|
| Olfaction Disorders | 1 | 2024 | 224 | 0.190 |
Why?
|
| Cranial Irradiation | 3 | 2019 | 390 | 0.180 |
Why?
|
| Brain Neoplasms | 6 | 2024 | 9031 | 0.160 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 48 | 0.160 |
Why?
|
| Organs at Risk | 3 | 2021 | 359 | 0.150 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 290 | 0.150 |
Why?
|
| Neuroma, Acoustic | 1 | 2022 | 459 | 0.150 |
Why?
|
| Neurosecretory Systems | 1 | 2019 | 223 | 0.150 |
Why?
|
| Optic Nerve | 2 | 2018 | 572 | 0.140 |
Why?
|
| Hypopituitarism | 1 | 2019 | 250 | 0.140 |
Why?
|
| Glioma | 3 | 2019 | 3455 | 0.130 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 1258 | 0.130 |
Why?
|
| Carotid Stenosis | 1 | 2023 | 860 | 0.130 |
Why?
|
| Radiation Tolerance | 3 | 2021 | 479 | 0.120 |
Why?
|
| Supratentorial Neoplasms | 2 | 2013 | 159 | 0.120 |
Why?
|
| Optic Nerve Diseases | 1 | 2018 | 342 | 0.120 |
Why?
|
| Hearing Loss | 1 | 2022 | 783 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 2 | 2013 | 586 | 0.120 |
Why?
|
| Medulloblastoma | 2 | 2013 | 678 | 0.110 |
Why?
|
| Auditory Perception | 6 | 1998 | 583 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2022 | 1342 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2013 | 136 | 0.100 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1324 | 0.100 |
Why?
|
| Cats | 4 | 1996 | 975 | 0.100 |
Why?
|
| Rhabdoid Tumor | 1 | 2013 | 210 | 0.090 |
Why?
|
| Pituitary Gland | 3 | 2019 | 635 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2018 | 1199 | 0.090 |
Why?
|
| Teratoma | 1 | 2013 | 404 | 0.090 |
Why?
|
| Nausea | 2 | 2024 | 679 | 0.080 |
Why?
|
| Vomiting | 2 | 2024 | 651 | 0.080 |
Why?
|
| Pons | 4 | 2000 | 240 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 2895 | 0.080 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2012 | 549 | 0.070 |
Why?
|
| Postmortem Changes | 1 | 2007 | 119 | 0.070 |
Why?
|
| Sound Localization | 2 | 2000 | 60 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2017 | 9280 | 0.070 |
Why?
|
| Multiple Sclerosis | 6 | 2000 | 3220 | 0.070 |
Why?
|
| Macaca | 1 | 2007 | 410 | 0.070 |
Why?
|
| Cauda Equina | 1 | 2005 | 45 | 0.060 |
Why?
|
| Hippocampus | 1 | 2018 | 3766 | 0.060 |
Why?
|
| Acoustic Stimulation | 4 | 2005 | 1235 | 0.060 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2010 | 491 | 0.060 |
Why?
|
| Child, Preschool | 9 | 2024 | 42230 | 0.060 |
Why?
|
| Ependymoma | 1 | 2008 | 320 | 0.060 |
Why?
|
| Adult | 24 | 2024 | 221203 | 0.060 |
Why?
|
| Skull Neoplasms | 2 | 2018 | 173 | 0.060 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2013 | 916 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2023 | 39107 | 0.060 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1987 | 530 | 0.060 |
Why?
|
| Neoplasms, Second Primary | 1 | 2012 | 1052 | 0.060 |
Why?
|
| Male | 30 | 2024 | 360842 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2021 | 36429 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2007 | 1085 | 0.050 |
Why?
|
| Orbital Neoplasms | 1 | 2005 | 222 | 0.050 |
Why?
|
| Noise | 1 | 2005 | 290 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2007 | 2257 | 0.050 |
Why?
|
| Stroke | 2 | 2023 | 9758 | 0.050 |
Why?
|
| Rhabdomyosarcoma | 1 | 2005 | 358 | 0.050 |
Why?
|
| Treatment Outcome | 8 | 2023 | 64684 | 0.050 |
Why?
|
| Female | 29 | 2024 | 392686 | 0.050 |
Why?
|
| Adolescent | 12 | 2024 | 88324 | 0.050 |
Why?
|
| Cognition | 2 | 2018 | 6992 | 0.050 |
Why?
|
| Humans | 39 | 2024 | 761572 | 0.050 |
Why?
|
| Child | 10 | 2024 | 80156 | 0.050 |
Why?
|
| Young Adult | 7 | 2024 | 59255 | 0.050 |
Why?
|
| Skull Base | 1 | 2023 | 292 | 0.040 |
Why?
|
| Radiometry | 2 | 2018 | 813 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 6815 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2024 | 54426 | 0.040 |
Why?
|
| Ear | 1 | 2000 | 172 | 0.040 |
Why?
|
| Infant | 6 | 2023 | 36192 | 0.040 |
Why?
|
| Infratentorial Neoplasms | 2 | 2013 | 98 | 0.040 |
Why?
|
| Skull | 1 | 2023 | 818 | 0.040 |
Why?
|
| Craniopharyngioma | 1 | 2021 | 277 | 0.040 |
Why?
|
| Hearing | 1 | 2022 | 501 | 0.040 |
Why?
|
| Brain Mapping | 2 | 2007 | 6635 | 0.040 |
Why?
|
| Thyroid Function Tests | 1 | 2019 | 288 | 0.040 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 265 | 0.040 |
Why?
|
| Aged | 11 | 2021 | 169310 | 0.030 |
Why?
|
| Middle Aged | 17 | 2021 | 220920 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 413 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1996 | 203 | 0.030 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1996 | 144 | 0.030 |
Why?
|
| Mental Processes | 1 | 1997 | 244 | 0.030 |
Why?
|
| Hypothalamus | 1 | 2001 | 999 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 3 | 2008 | 882 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2000 | 983 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1893 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2022 | 80646 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1552 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 12059 | 0.030 |
Why?
|
| Vision Disorders | 1 | 2021 | 1088 | 0.030 |
Why?
|
| Echo-Planar Imaging | 1 | 1998 | 663 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1256 | 0.030 |
Why?
|
| Chondroma | 1 | 1992 | 53 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1998 | 1474 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 1992 | 98 | 0.020 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1992 | 228 | 0.020 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 249 | 0.020 |
Why?
|
| Germinoma | 1 | 2010 | 132 | 0.020 |
Why?
|
| Carcinoma | 1 | 2021 | 2330 | 0.020 |
Why?
|
| Cochlear Nerve | 1 | 1990 | 202 | 0.020 |
Why?
|
| Reaction Time | 3 | 1998 | 2089 | 0.020 |
Why?
|
| Memory | 1 | 2018 | 2193 | 0.020 |
Why?
|
| Survival Rate | 3 | 2010 | 12725 | 0.020 |
Why?
|
| Cochlea | 2 | 2012 | 845 | 0.020 |
Why?
|
| Electrophysiology | 3 | 1996 | 1262 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2013 | 781 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1570 | 0.020 |
Why?
|
| Quality of Life | 2 | 2019 | 13367 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 2005 | 372 | 0.020 |
Why?
|
| Stapedius | 1 | 1985 | 26 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 7054 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1998 | 3049 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 3514 | 0.010 |
Why?
|
| Prognosis | 2 | 2019 | 29629 | 0.010 |
Why?
|
| Psychoacoustics | 2 | 1995 | 55 | 0.010 |
Why?
|
| Animals | 7 | 2007 | 168467 | 0.010 |
Why?
|
| Species Specificity | 1 | 1987 | 2414 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3683 | 0.010 |
Why?
|
| Facial Nerve | 1 | 1985 | 277 | 0.010 |
Why?
|
| Auditory Threshold | 2 | 1995 | 369 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13510 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2005 | 333 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2644 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 58986 | 0.010 |
Why?
|
| Neurons | 2 | 1996 | 9463 | 0.010 |
Why?
|
| Brain | 4 | 2012 | 27120 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21355 | 0.010 |
Why?
|
| Hyperprolactinemia | 1 | 2001 | 124 | 0.010 |
Why?
|
| Muscles | 1 | 1985 | 1576 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1987 | 1496 | 0.010 |
Why?
|
| Motor Neurons | 1 | 1985 | 870 | 0.010 |
Why?
|
| Risk | 1 | 2012 | 9610 | 0.010 |
Why?
|
| Fetal Hypoxia | 1 | 1979 | 30 | 0.010 |
Why?
|
| Dichotic Listening Tests | 1 | 1998 | 22 | 0.010 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 716 | 0.010 |
Why?
|
| Asphyxia Neonatorum | 1 | 1979 | 111 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 1979 | 278 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6228 | 0.010 |
Why?
|
| Nissl Bodies | 1 | 1996 | 16 | 0.010 |
Why?
|
| Neuropsychology | 1 | 1997 | 107 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2001 | 668 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 39970 | 0.010 |
Why?
|
| Hypogonadism | 1 | 2001 | 798 | 0.010 |
Why?
|
| Audiometry | 1 | 1995 | 253 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2013 | 26198 | 0.010 |
Why?
|
| Axons | 2 | 1996 | 1674 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 5247 | 0.010 |
Why?
|
| Cranial Nerve Injuries | 1 | 1992 | 28 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 74213 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 4920 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13642 | 0.010 |
Why?
|
| Speech Perception | 1 | 1994 | 509 | 0.010 |
Why?
|
| Cricetinae | 1 | 1993 | 2423 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 1882 | 0.000 |
Why?
|
| Learning | 1 | 1997 | 1740 | 0.000 |
Why?
|
| Models, Neurological | 1 | 1995 | 1769 | 0.000 |
Why?
|
| Heart Rate | 1 | 1998 | 4195 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1998 | 8528 | 0.000 |
Why?
|
| Chorda Tympani Nerve | 1 | 1985 | 11 | 0.000 |
Why?
|
| Nerve Endings | 1 | 1983 | 105 | 0.000 |
Why?
|
| Vagus Nerve | 1 | 1985 | 458 | 0.000 |
Why?
|
| Cell Count | 1 | 1985 | 1835 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 2561 | 0.000 |
Why?
|
| Nerve Fibers | 1 | 1983 | 708 | 0.000 |
Why?
|
| Haplorhini | 1 | 1979 | 525 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20571 | 0.000 |
Why?
|
| Synapses | 1 | 1983 | 1769 | 0.000 |
Why?
|
| Evoked Potentials | 1 | 1979 | 1047 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1979 | 2329 | 0.000 |
Why?
|
| Pregnancy | 1 | 1979 | 29876 | 0.000 |
Why?
|